Does CARMENA mark the end of cytoreductive nephrectomy for metastatic renal cell carcinoma?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Does CARMENA mark the end of cytoreductive nephrectomy for metastatic renal cell carcinoma?

Published:2019-08 Issue:8 Volume:37 Page:525-528
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Chang Steven L.^ORCID,Choueiri Toni K.^ORCID,Harshman Lauren C.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference32 articles.

1. Non-clear cell renal cell carcinoma, part 1: histology;Valenca;Clin Adv Hematol Oncol,2015

2. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer;Flanigan;NEJM,2001

3. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial;Mickisch;The Lancet,2001

4. Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis;Flanigan;J Urol,2004

5. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study;Heng;J Clin Oncol,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP